Treace Medical Concepts, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Treace Medical Concepts, Inc. (TMCI) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 54.83 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-06
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 54.83M shares, a 44.84% increase year-over-year.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 53.85M shares, a 45.21% increase year-over-year.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 52.77M shares, a 42.34% increase year-over-year.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 49.19M shares, a 32.69% increase year-over-year.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 48.42M shares, a 30.61% increase from fiscal 2020.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 37.07M shares, a 0.43% increase from fiscal 2019.
- Treace Medical Concepts, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 36.91M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | 54.83M shares 10-Q · filed 2022-05-06 | 54.34M shares derived: average of 2 quarters · filed 2022-05-06 | 53.82M shares derived: average of 3 quarters · filed 2022-05-06 | 52.66M shares derived: average of 4 quarters · filed 2022-05-06 |
| 2021-12-31 | 53.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | 53.31M shares derived: average of 2 quarters · filed 2022-03-04 | 51.94M shares derived: average of 3 quarters · filed 2022-03-04 | 48.42M shares 10-K · filed 2022-03-04 |
| 2021-09-30 | 52.77M shares 10-Q · filed 2021-11-04 | 50.98M shares derived: average of 2 quarters · filed 2021-11-04 | 46.60M shares 10-Q · filed 2021-11-04 | 44.22M shares derived: average of 4 quarters · filed 2022-05-06 |
| 2021-06-30 | 49.19M shares 10-Q · filed 2021-08-05 | 43.56M shares 10-Q · filed 2021-08-05 | 41.38M shares derived: average of 3 quarters · filed 2022-05-06 | 40.30M shares derived: average of 4 quarters · filed 2022-05-06 |
| 2021-03-31 | 37.85M shares 10-Q · filed 2022-05-06 | 37.47M shares derived: average of 2 quarters · filed 2022-05-06 | 37.34M shares derived: average of 3 quarters · filed 2022-05-06 | 37.27M shares derived: average of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | 37.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | 37.08M shares derived: average of 2 quarters · filed 2022-03-04 | 37.07M shares derived: average of 3 quarters · filed 2022-03-04 | 37.07M shares 10-K · filed 2022-03-04 |
| 2020-09-30 | 37.07M shares 10-Q · filed 2021-11-04 | 37.07M shares derived: average of 2 quarters · filed 2021-11-04 | 37.06M shares 10-Q · filed 2021-11-04 | |
| 2020-06-30 | 37.07M shares 10-Q · filed 2021-08-05 | 37.06M shares 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | 37.05M shares 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | 36.91M shares 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |